๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Pharmacokinetics

Safety, Pharmacokinetics (PK), and Efficacy of ONC-783 in Advanced Solid Tumors NCT07408258Phase 13 sites๐Ÿ“ New York๐Ÿ“ Philadelphia๐Ÿ“ Houston OncoC4, Inc. ยท Tests: ONC-783 A Phase I First-in-Human Study of GenSci128 in Patients With Solid Tumors Harboring a TP53 Y220C Mutation NCT06908434Phase 11 site๐Ÿ“ Shanghai Changchun GeneScience Pharmaceutical Co., Ltd. ยท Tests: GenSci128 tablets VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma NCT03556228Phase 1, Phase 215 sites๐Ÿ“ Santa Rosa๐Ÿ“ Hartford๐Ÿ“ Washington D.C. VM Oncology, LLC ยท Tests: VMD-928 100 mg Tablet, VMD-928 Tablet and Pembrolizumab (200 mg) Study to Assess the Use of Tezampanel for Opioid Withdrawal Syndrome in Treatment-Seeking Patients With Opioid Use Disorder NCT06538558Phase 11 site๐Ÿ“ Indianapolis Proniras Corporation ยท Tests: Tezampanel, Placebo Phase 1 Study to Evaluate Safety and Antiviral Activity of PBGENE-HBV in Adult Patients With Chronic Hepatitis B NCT06680232Phase 17 sites๐Ÿ“ Boston๐Ÿ“ Clichy๐Ÿ“ Hong Kong Precision BioSciences, Inc. ยท Tests: PBGENE-HBV A Study to Learn How Different Amounts of the Study Medicine Called PF-08065010 Are Tolerated and Act in the Body of Healthy Adults NCT07235163Phase 11 site๐Ÿ“ Brussels Pfizer ยท Tests: PF-08065010, Placebo TGRX-1942 Chinese Phase I for Advanced Solid Tumor And/or Relapsed/Refractory Hematologic Malignancies NCT06484816Phase 11 site๐Ÿ“ Hangzhou Shenzhen TargetRx Co., Ltd. ยท Tests: TGRX-1942 Evaluation of NBI-1117570 in Inpatient Adults With Schizophrenia NCT07288333Phase 26 sites๐Ÿ“ Kazanlak๐Ÿ“ Pazardzhik๐Ÿ“ Targovishte Neurocrine Biosciences ยท Tests: NBI-1117570, Placebo A Study to Evaluate Efficacy, Safety, and PK of XEMBIFYยฎ+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma NCT05645107Phase 362 sites๐Ÿ“ Bullhead City๐Ÿ“ Huntington Park๐Ÿ“ St. Petersburg Grifols Therapeutics LLC ยท Tests: Xembify, Placebo A Research Study on How UBT251 Affects Levels of Midazolam, Caffeine and Warfarin in the Blood of Participants With Excess Body Weight NCT07710768Phase 11 site๐Ÿ“ Cypress Novo Nordisk A/S ยท Tests: UBT251, Cocktail (Warfarin/Caffeine/Midazolam) Bariatric Surgery and Pharmacokinetics of Fluoxetine NCT03476525n/a1 site๐Ÿ“ Trondheim Norwegian University of Science and Technology ยท Tests: Fluoxetine A Three-part First-in-human Trial to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GUB-UCN2 in Healthy Lean and Obese Participants and Participants With T2D NCT07702890Phase 1, Phase 21 site๐Ÿ“ Neuss Gubra A/S ยท Tests: GUB-UCN2, Placebo A Study of MT-4561 in Patients With Various Advanced Solid Tumors NCT06943521Phase 1, Phase 26 sites๐Ÿ“ Los Angeles๐Ÿ“ Grand Rapids๐Ÿ“ Columbus Tanabe Pharma America, Inc. ยท Tests: MT-4561 A Study to Investigate Pharmacokinetics (PK), Safety, and Tolerability of VH4367310 in Healthy Adult Participants NCT07818915Phase 12 sites๐Ÿ“ Glendale๐Ÿ“ Baltimore ViiV Healthcare ยท Tests: VH4367310, Placebo A Study to Learn About the Safety and Effects of the Study Drug PRX-102 in Children and Adolescents With Fabry Disease NCT06328608Phase 2, Phase 312 sites๐Ÿ“ Phoenix๐Ÿ“ Atlanta๐Ÿ“ Iowa City Chiesi Farmaceutici S.p.A. ยท Tests: PRX-102 1 mg/kg every two weeks A Phase Ib Study of APG-115 Single Agent or in Combination With Azacitidine or Cytarabine in Patients With AML and MDS. NCT04275518Phase 114 sites๐Ÿ“ Beijing๐Ÿ“ Guangzhou๐Ÿ“ Guangzhou Ascentage Pharma Group Inc. ยท Tests: APG-115, Azacitidine, Cytarabine Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036) NCT05714085Phase 2, Phase 3111 sites๐Ÿ“ Los Angeles๐Ÿ“ Palo Alto๐Ÿ“ San Bernardino Merck Sharp & Dohme LLC ยท Tests: Vericiguat tablet, Vericiguat suspension, Placebo tablet, Placebo suspension A Study of BL-B01D1 in Patients With Multiple Solid Tumors, Including Recurrent or Metastatic Gynecological Malignancies NCT05803018Phase 1, Phase 21 site๐Ÿ“ Shanghai Sichuan Baili Pharmaceutical Co., Ltd. ยท Tests: BL-B01D1 Phase Ib Study of Efsubaglutide Alfa Injection in Obese Adolescents NCT07693426Phase 15 sites๐Ÿ“ Beijing๐Ÿ“ Wuhan๐Ÿ“ Shenyang Shanghai Yinnuo Pharmaceutical Technology Co., Ltd. ยท Tests: Efsubaglutide Alfa 5 mg QW, Efsubaglutide Alfa 10 mg QW, Efsubaglutide Alfa 20 mg QW, Efsubaglutide Alfa placebo A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASC35 Injection in Participants With Obesity or Overweight NCT07842640Phase 11 site๐Ÿ“ Baltimore Ascletis Pharma (China) Co., Limited ยท Tests: ASC35 Injection B, for subcutaneous use, ASC35 Placebo Injection B, for subcutaneous use, Tirzepatide A First-in-Human, JAB-8263 in Adult Patients With Advanced Tumors NCT04686682Phase 1, Phase 21 site๐Ÿ“ Tianjin Jacobio Pharmaceuticals Co., Ltd. ยท Tests: JAB-8263, JAB-8263 A Study of AK109 Combined With AK104 in Patients With Advanced Solid Tumors NCT05142423Phase 1, Phase 21 site๐Ÿ“ Hangzhou Akeso ยท Tests: AK109+AK104 A Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SV003 in Healthy Participants. NCT07469085Phase 11 site๐Ÿ“ Shanghai Shanghai Synvida Biotechnology Co.,Ltd. ยท Tests: SV003, Placebo Exenatide Pharmacokinetics and Pharmacodynamics in Gestational Diabetes NCT05482789Phase 41 site๐Ÿ“ Pittsburgh Maisa N. Feghali, MD ยท Tests: Exenatide DXP-106 in Solid Tumor Patients. NCT07532018Phase 14 sites๐Ÿ“ Harbin๐Ÿ“ Shanghai๐Ÿ“ Taiyuan Singlomics Biopharmaceuticals Zhuhai Co., Ltd. ยท Tests: DXP-106 A Study of OL-108 in Relapsed/Refractory Autoimmune Diseases NCT06980597Phase 12 sites๐Ÿ“ Beijing๐Ÿ“ Beijing Beijing GoBroad Hospital ยท Tests: OL-108 Phase I Study of HMPL-306 for the Treatment of Gliomas With IDH1 and/or IDH2 Mutations NCT07025018Phase 11 site๐Ÿ“ Shanghai Hutchmed ยท Tests: HMPL-306 A Single-Center, Open-Label, Single Ascending Dose Study of Exenatide Circular RNA-Lipid Nanoparticle Injection (CR059) in Chinese Subjects With Type 2 Diabetes Mellitus NCT07347080EARLY Phase 11 site๐Ÿ“ Luoyang The First Affiliated Hospital of Henan University of Sciencโ€ฆ ยท Tests: Exenatide Circular RNA-Lipid Nanoparticle Injection๏ผˆ CR059๏ผ‰๏ผ‰ A Study of NHL907 in Healthy Adult Participants NCT07580924Phase 11 site๐Ÿ“ Adelaide NeuHyll AUS Pty Ltd ยท Tests: NHL907, Placebo A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate Cancer NCT06609005Phase 1, Phase 222 sites๐Ÿ“ Scottsdale๐Ÿ“ Newport Beach๐Ÿ“ Orange Shenzhen Ionova Life Sciences Co., Ltd. ยท Tests: INV-9956
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy